Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (n-methyl-(11c))vorozole
2. 6-((4-chlorophenyl)-(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzotriazole
3. R 76713
4. R 83839
5. R 83842
6. R-76713
7. R-83839
8. R-83842
9. Vorozole
10. Vorozole, (+)-isomer
1. Vorozole
2. 129731-10-8
3. R-83842
4. 1e2s9yxv2a
5. R 83842
6. 6-[(s)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole
7. Vorozolum
8. Vorozol
9. 1h-benzotriazole, 6-((4-chlorophenyl)-1h-1,2,4-triazol-1-ylmethyl)-1-methyl-, (s)-
10. (s)-6-((4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzo[d][1,2,3]triazole
11. Vorozol [inn-spanish]
12. Vorozolum [inn-latin]
13. Unii-1e2s9yxv2a
14. Vorozole [usan:inn:ban]
15. Ccris 7482
16. Rivizor (tn)
17. Vorozole [usan]
18. Vorozole (usan/inn)
19. Vorozole [inn]
20. Vorozole [mi]
21. (s)-vorozole
22. Vorozole [mart.]
23. Vorozole [who-dd]
24. Schembl4554
25. Chembl224060
26. Dtxsid20156230
27. Chebi:135387
28. Bcp04202
29. Zinc3791538
30. Bdbm50378780
31. Db13767
32. (+)-(s)-6-(p-chloro-alpha-1h-1,2,4-triazol-1-ylbenzyl)-1-methyl-1h-benzotriazole
33. R76713
34. Hy-19599
35. Bcp0726000088
36. Cs-0015881
37. D03786
38. R-83942
39. Q7941876
40. (+)-(s)-6-(p-chloro-a-1h-1,2,4-triazol-1-ylbenzyl)-1-methyl-1h-benzotriazole
41. (+)-6-[(4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl]-1-methyl-1h- Benzotriazole
42. (s)-6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole
43. 1-methyl-6-[(s)-alpha-(1h-1,2,4-triazol-1-yl)-4-chlorobenzyl]-1h-benzotriazole
Molecular Weight | 324.77 g/mol |
---|---|
Molecular Formula | C16H13ClN6 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 324.0890221 g/mol |
Monoisotopic Mass | 324.0890221 g/mol |
Topological Polar Surface Area | 61.4 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 402 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Aromatase Inhibitors
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones. (See all compounds classified as Aromatase Inhibitors.)
L - Antineoplastic and immunomodulating agents
L02 - Endocrine therapy
L02B - Hormone antagonists and related agents
L02BG - Aromatase inhibitors
L02BG05 - Vorozole
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?